• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

增强型纳米囊泡 DNA 疫苗载体在呼吸道合胞病毒中的传递和表达。

Enhanced delivery and expression of a nanoencapsulated DNA vaccine vector for respiratory syncytial virus.

机构信息

Center for NanoBiotechnology Research, Alabama State University, Montgomery, Alabama, USA.

出版信息

Nanomedicine. 2009 Dec;5(4):463-72. doi: 10.1016/j.nano.2009.02.004. Epub 2009 Mar 31.

DOI:10.1016/j.nano.2009.02.004
PMID:19341819
Abstract

UNLABELLED

This study evaluated the efficiency of chitosan-encapsulated DNA-based respiratory syncytial virus (RSV) vaccine. Antigenic regions of RSV F, M2, and G genes were cloned into the human cytomegalovirus promoter-based constitutive expression vector, resulting in a DNA vaccine vector named DR-FM2G. This vector was used to formulate DNA-chitosan nanoparticles (DCNPs) using a complex coacervation process that yielded an encapsulation efficiency of 94.7%. The DCNP sizes ranged from 80 to 150 nm with uniform size distribution and spherical shape. DNA release was between 50% and 60% when DCNPs were incubated with similar gastrointestinal fluid (pH 2), whereas 21% to 25% of DNA was released from DCNPs in 30 minutes at pH 10. Differential scanning calorimetry showed DCNPs to be more stable than naked DNA or chitosan, offering protection from DNA degradation by nucleases. DCNPs were not toxic to cells when used at concentrations < or =400 microg/mL. Immunohistochemical and real-time polymerase chain reaction results showed a higher level of RSV protein expression in mouse tissues given when DCNPs were injected intravenously as compared with naked DNA.

FROM THE CLINICAL EDITOR

This study evaluated the efficiency of chitosan-encapsulated DNA-based respiratory syncytial virus (RSV) vaccine, showing a higher level of RSV protein expression in mouse tissues given when DCNPs were injected intravenously as compared with naked DNA.

摘要

未加标签

本研究评估了壳聚糖包封的 DNA 基于呼吸道合胞病毒(RSV)疫苗的效率。RSV F、M2 和 G 基因的抗原区域被克隆到人巨细胞病毒启动子组成型表达载体中,得到一种名为 DR-FM2G 的 DNA 疫苗载体。该载体用于通过复杂共凝聚过程来制备 DNA-壳聚糖纳米颗粒(DCNP),得到的包封效率为 94.7%。DCNP 的粒径范围为 80 至 150nm,具有均匀的粒径分布和球形。当 DCNP 在类似的胃肠液(pH2)中孵育时,DNA 释放量在 50%至 60%之间,而在 pH10 时,21%至 25%的 DNA 从 DCNP 中释放出来。差示扫描量热法表明 DCNP 比裸露 DNA 或壳聚糖更稳定,能够保护 DNA 免受核酸酶的降解。当使用浓度<或=400μg/ml 时,DCNP 对细胞没有毒性。免疫组织化学和实时聚合酶链反应结果表明,与裸露 DNA 相比,静脉内注射 DCNP 时,小鼠组织中 RSV 蛋白的表达水平更高。

临床编辑点评

本研究评估了壳聚糖包封的 DNA 基于呼吸道合胞病毒(RSV)疫苗的效率,与裸露 DNA 相比,静脉内注射 DCNP 时,小鼠组织中 RSV 蛋白的表达水平更高。

相似文献

1
Enhanced delivery and expression of a nanoencapsulated DNA vaccine vector for respiratory syncytial virus.增强型纳米囊泡 DNA 疫苗载体在呼吸道合胞病毒中的传递和表达。
Nanomedicine. 2009 Dec;5(4):463-72. doi: 10.1016/j.nano.2009.02.004. Epub 2009 Mar 31.
2
A nonviral pHEMA+chitosan nanosphere-mediated high-efficiency gene delivery system.一种非病毒 pHEMA+壳聚糖纳米球介导的高效基因传递系统。
Int J Nanomedicine. 2013;8:1403-15. doi: 10.2147/IJN.S43168. Epub 2013 Apr 11.
3
RSV fusion (F) protein DNA vaccine provides partial protection against viral infection.呼吸道合胞病毒融合(F)蛋白DNA疫苗对病毒感染提供部分保护。
Virus Res. 2009 Oct;145(1):39-47. doi: 10.1016/j.virusres.2009.06.012. Epub 2009 Jun 21.
4
Combined virus-like particle and fusion protein-encoding DNA vaccination of cotton rats induces protection against respiratory syncytial virus without causing vaccine-enhanced disease.联合病毒样颗粒和编码融合蛋白的DNA疫苗接种棉鼠可诱导对呼吸道合胞病毒的保护作用,且不会引起疫苗增强性疾病。
Virology. 2016 Jul;494:215-24. doi: 10.1016/j.virol.2016.04.014. Epub 2016 Apr 26.
5
Chimeric bovine/human parainfluenza virus type 3 expressing respiratory syncytial virus (RSV) F glycoprotein: effect of insert position on expression, replication, immunogenicity, stability, and protection against RSV infection.嵌合牛/人副流感病毒 3 型表达呼吸道合胞病毒 (RSV) F 糖蛋白:插入位置对表达、复制、免疫原性、稳定性和预防 RSV 感染的影响。
J Virol. 2014 Apr;88(8):4237-50. doi: 10.1128/JVI.03481-13. Epub 2014 Jan 29.
6
Membrane-associated respiratory syncytial virus F protein expressed from a human rhinovirus type 14 vector is immunogenic.由14型人鼻病毒载体表达的膜相关呼吸道合胞病毒F蛋白具有免疫原性。
Virology. 2001 Mar 15;281(2):216-30. doi: 10.1006/viro.2000.0796.
7
Oral respiratory syncytial virus (RSV) DNA vaccine expressing RSV F protein delivered by attenuated Salmonella typhimurium.由减毒鼠伤寒沙门氏菌递送的表达呼吸道合胞病毒(RSV)F蛋白的口服RSV DNA疫苗。
Hum Gene Ther. 2007 Aug;18(8):746-52. doi: 10.1089/hum.2007.053.
8
Attenuated Human Parainfluenza Virus Type 1 Expressing the Respiratory Syncytial Virus (RSV) Fusion (F) Glycoprotein from an Added Gene: Effects of Prefusion Stabilization and Packaging of RSV F.表达来自附加基因的呼吸道合胞病毒(RSV)融合(F)糖蛋白的减毒1型人副流感病毒:RSV F的预融合稳定化和包装的影响
J Virol. 2017 Oct 27;91(22). doi: 10.1128/JVI.01101-17. Print 2017 Nov 15.
9
Enhancement of mucosal and cellular immune response in mice by vaccination with respiratory syncytial virus DNA encapsulated with transfersome.用包裹有传递体的呼吸道合胞病毒DNA疫苗接种增强小鼠的黏膜和细胞免疫反应。
Viral Immunol. 2008 Dec;21(4):483-9. doi: 10.1089/vim.2008.0044.
10
Pulmonary delivery of respiratory syncytial virus DNA vaccines using macroaggregated albumin particles.使用大聚合白蛋白颗粒进行呼吸道合胞病毒DNA疫苗的肺部递送。
Vaccine. 2004 Jun 2;22(17-18):2248-60. doi: 10.1016/j.vaccine.2003.11.050.

引用本文的文献

1
Nucleic acid vaccines: innovations, efficacy, and applications in at-risk populations.核酸疫苗:创新、疗效及在高危人群中的应用
Front Immunol. 2025 May 14;16:1584876. doi: 10.3389/fimmu.2025.1584876. eCollection 2025.
2
Histochemistry for Molecular Imaging in Nanomedicine.纳米医学中的分子影像学中的组织化学。
Int J Mol Sci. 2024 Jul 24;25(15):8041. doi: 10.3390/ijms25158041.
3
PLGA-Chitosan Encapsulated IL-10 Nanoparticles Modulate Chlamydia Inflammation in Mice.PLGA-壳聚糖包载 IL-10 纳米颗粒调控小鼠沙眼衣原体感染炎症反应
Int J Nanomedicine. 2024 Feb 8;19:1287-1301. doi: 10.2147/IJN.S432970. eCollection 2024.
4
From Bench to the Clinic: The Path to Translation of Nanotechnology-Enabled mRNA SARS-CoV-2 Vaccines.从实验室到临床:基于纳米技术的新冠mRNA疫苗的转化之路
Nanomicro Lett. 2022 Jan 3;14(1):41. doi: 10.1007/s40820-021-00771-8.
5
Potential of polylactic-co-glycolic acid (PLGA) for delivery Jembrana disease DNA vaccine Model (pEGFP-C1-tat).聚乳酸-共-羟基乙酸(PLGA)作为杰彭那病 DNA 疫苗模型(pEGFP-C1-tat)的递药载体的潜力。
J Vet Sci. 2021 Nov;22(6):e76. doi: 10.4142/jvs.2021.22.e76. Epub 2021 Aug 30.
6
ACE2-cytomimetic particles restrict SARS-Cov-2 spike protein binding to cellular targets.模拟ACE2的颗粒可限制新冠病毒刺突蛋白与细胞靶点的结合。
Biotechnol Rep (Amst). 2021 Dec;32:e00681. doi: 10.1016/j.btre.2021.e00681. Epub 2021 Sep 30.
7
Effect of the cagW-based gene vaccine on the immunologic properties of BALB/c mouse: an efficient candidate for Helicobacter pylori DNA vaccine.基于 cagW 基因疫苗对 BALB/c 鼠免疫特性的影响:幽门螺杆菌 DNA 疫苗的有效候选者。
J Nanobiotechnology. 2020 Apr 21;18(1):63. doi: 10.1186/s12951-020-00618-1.
8
Chitosan-DNA nanoparticles enhanced the immunogenicity of multivalent DNA vaccination on mice against Trueperella pyogenes infection.壳聚糖-DNA 纳米颗粒增强了多价 DNA 疫苗对化脓隐秘杆菌感染小鼠的免疫原性。
J Nanobiotechnology. 2018 Jan 29;16(1):8. doi: 10.1186/s12951-018-0337-2.
9
Synthetic Biodegradable Microparticle and Nanoparticle Vaccines against the Respiratory Syncytial Virus.针对呼吸道合胞病毒的合成可生物降解微粒和纳米颗粒疫苗。
Vaccines (Basel). 2016 Dec 2;4(4):45. doi: 10.3390/vaccines4040045.
10
IgA response and protection following nasal vaccination of chickens with Newcastle disease virus DNA vaccine nanoencapsulated with Ag@SiO2 hollow nanoparticles.用Ag@SiO2空心纳米颗粒包封的新城疫病毒DNA疫苗经鼻腔接种鸡后IgA反应及保护作用
Sci Rep. 2016 May 12;6:25720. doi: 10.1038/srep25720.